CRISPR

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

407

Employees407

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

407

Employees407

CRSP Key Statistics

Market cap

3.57B

Market cap3.57B

Price-Earnings ratio

-14.81

Price-Earnings ratio-14.81

Dividend yield

—

Dividend yield—

Average volume

2.14M

Average volume2.14M

High today

$42.39

High today$42.39

Low today

$40.95

Low today$40.95

Open price

$41.93

Open price$41.93

Volume

1.43M

Volume1.43M

52 Week high

$91.10

52 Week high$91.10

52 Week low

$36.52

52 Week low$36.52

CRSP News

TipRanks 6d

Bargain Basement CRISPR Therapeutics Becomes Takeover Target

CRISPR Therapeutics (CRSP) has underperformed the market and my expectations over the past year. In fact, the stock has lost a third of its share price value an...

Analyst ratings

52%

of 31 ratings

Buy

51.6%

Hold

41.9%

Sell

6.5%